🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Kidney Transplant; Complications

Evaluation of Dipyridamole in Preventing Post-Transplant Hypophosphatemia in Kidney Transplant Recipients NCT06824454Phase 21 site📍 Stanford Stanford University · Tests: Dipyridamole 75 MG Studies on Adsorption International Learning Initiative Global NCT07123909NA1 site📍 Moscow Botkin Hospital · Tests: Patients will undergo a combined hemodialysis and hemosorption procedure. The study cartridge for hemosorption by Jafro… Double Voiding and Post-transplant UTI NCT05711446NA1 site📍 New York Weill Medical College of Cornell University · Tests: Double Voiding, Regular Voiding Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transplantation NCT06560801Phase 41 site📍 Erlangen University of Erlangen-Nürnberg Medical School · Tests: Dapagliflozin 10mg Tab ICHARUS: Italian Cooperative HemoAdsorption Study for Relief of Uremic Symptoms NCT07522008n/a1 site📍 Cagliari Azienda Ospedaliera Brotzu The KidneyCARE (Community Access to Research Equity) Study NCT05497518n/a1 site📍 Danville Tufts Medical Center · Tests: Observational study - registry Hyperthyroidism as a Potential Predictive of Worse Outcome of Renal Graft NCT06794203n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders NCT06434363Phase 1, Phase 22 sites📍 Houston📍 Houston M.D. Anderson Cancer Center · Tests: Tafasitamab, Fludarabine phosphate, Cyclophosphamide, Tafasitamab and NK cells NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities NCT06810622NA2 sites📍 Denver📍 Albuquerque University of Colorado, Denver · Tests: Community health worker intervention, Standard Care (in control arm) The Impact of Intraoperative Diuretic Use on Delayed Graft Function Following Deceased Donor Renal Transplantation NCT07726134NA2 sites📍 London📍 London London Health Sciences Centre Research Institute OR Lawson … · Tests: Furosemide, Mannitol Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive Donors NCT05159466n/a1 site📍 Metairie Tulane University · Tests: Kidney transplant Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients NCT06140537Phase 41 site📍 Aurora University of Colorado, Denver · Tests: Dapagliflozin 10mg Tab, Placebo Immunological Reset to Allow Access to HLA Compatible Transplantation in Highly Sensitized Kidney Transplant Candidates Through Non-myeloablative Autologous Stemm Cell Transplantation NCT06809075NA1 site📍 Barcelona Hospital Universitari Vall d'Hebron Research Institute · Tests: hematopoietic precursor transplantation (TPHa) CAR-T Cell Therapy for Desensitization in Kidney Transplantation NCT06056102Phase 13 sites📍 Boston📍 New York📍 Philadelphia National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Cyclophosphamide, CART-BCMA, huCART19 Knowledge of Cardiovascular Risk Factors in Chronic Kidney Disease Patients NCT06674031n/a1 site📍 Ankara Hacettepe University Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion NCT05782543NA3 sites📍 Groningen📍 Leiden📍 Rotterdam University Medical Center Groningen · Tests: Normothermic machine perfusion Randomized Trial of SGLT2i in Heart Transplant Recipients NCT06625073Phase 46 sites📍 Palo Alto📍 Nashville📍 Houston VA Office of Research and Development · Tests: Empagliflozin, Placebo The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study NCT06059664Phase 21 site📍 Chapel Hill University of North Carolina, Chapel Hill · Tests: Finerenone Oral Tablet, Placebo Kidney Transplant Improvement Through New Exercise Training to Increase Capacity NCT07446296NA1 site📍 Philadelphia University of Pennsylvania · Tests: Exercise Rehabilitation Program with Physical Activity Tracker, Active control Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation NCT05679024Phase 334 sites📍 Helsinki📍 Tampere📍 Turku Region Stockholm · Tests: Apixaban 2.5 milligram Oral Tablet Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant NCT05027906Phase 1, Phase 29 sites📍 Cincinnati📍 Camperdown📍 Adelaide Eledon Pharmaceuticals · Tests: AT-1501 BIOmarkers Before and After Kidney Transplantation NCT06810258n/a1 site📍 Créteil Assistance Publique - Hôpitaux de Paris · Tests: Blood sample during native kidney biopsy, Blood sample during renal graft biopsy, Urine sample during renal graft biops… FMT in Checkpoint Inhibitor-mediated Diarrhea and Colitis NCT06206707NA1 site📍 Aarhus N University of Aarhus · Tests: Faecal Microbiota Transplantation (FMT), Placebo Acoustic Analysis of VA Sounds NCT05612022n/a1 site📍 Bergamo Mario Negri Institute for Pharmacological Research · Tests: AVF creation, AVG creation Addition of Venetoclax to Combined Hematopoietic Stem Cell and Kidney Transplantation NCT07358195EARLY Phase 11 site📍 Boston Massachusetts General Hospital · Tests: Venetoclax, Hematopoietic Cell Transplantation Conditioning Regimen, Kidney Transplant, Hematopoietic Cell Transplantat… Proteinuria in Pre and Post Transplant NCT01094327n/a1 site📍 Miami University of Miami SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF NCT05852704Phase 38 sites📍 Brno📍 Aarhus📍 Copenhagen Region Örebro County · Tests: Dapagliflozin 10mg Tab, Placebo Tab Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site📍 Chicago Northwestern University A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population NCT07006831n/a6 sites📍 San Diego📍 San Francisco📍 Atlanta Devyser Inc. TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation NCT06829719NA4 sites📍 Bordeaux (France)📍 Lyon📍 Strasbourg (france) Hospices Civils de Lyon · Tests: TTV DNAemia, EQ-5D-5L questionnaire, Biological tests
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy